Literature DB >> 19923332

Therapeutic options for systemic right ventricular failure.

P Szymañski, A Klisiewicz, P Hoffman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19923332     DOI: 10.1136/hrt.2009.179952

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  6 in total

1.  Introduction to the series: challenges and opportunities in pediatric heart failure and transplantation.

Authors:  Daniel Bernstein
Journal:  Circulation       Date:  2014-01-07       Impact factor: 29.690

2.  Renin-Angiotensin-Aldosterone System Inhibitors for Right Ventricular Dysfunction in Tetralogy of Fallot: Quo Vadis?

Authors:  Sushma Reddy; Daniel Bernstein; Jane W Newburger
Journal:  Circulation       Date:  2018-04-03       Impact factor: 29.690

Review 3.  Molecular Mechanisms of Right Ventricular Failure.

Authors:  Sushma Reddy; Daniel Bernstein
Journal:  Circulation       Date:  2015-11-03       Impact factor: 29.690

4.  Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

Authors:  Nicole Martin; Karthick Manoharan; Ceri Davies; R Thomas Lumbers
Journal:  Cochrane Database Syst Rev       Date:  2021-05-22

Review 5.  Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.

Authors:  Nicole Martin; Karthick Manoharan; James Thomas; Ceri Davies; R Thomas Lumbers
Journal:  Cochrane Database Syst Rev       Date:  2018-06-28

6.  Loss of cardiac myosin light chain kinase contributes to contractile dysfunction in right ventricular pressure overload.

Authors:  Vidhya Prasad; Nour Makkaoui; Rohan Rajan; Alisha Patel; Bipul Mainali; Pritha Bagchi; Rhea Kumar; Julia Rogers; Jake Diamond; Joshua T Maxwell
Journal:  Physiol Rep       Date:  2022-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.